XML 69 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
(Millions)202320222021
Cost of sales$44 $48 $47 
Selling, general and administrative expenses186 169 185 
Research, development and related expenses44 46 42 
Stock-based compensation expenses274 263 274 
Income tax benefits(45)(62)(100)
Stock-based compensation expenses (benefits), net of tax$229 $201 $174 
Schedule of Stock Option Activity The following table summarizes stock option activity:
(Options in thousands)Number of OptionsWeighted Average Exercise PriceWeighted Average
Remaining Contractual Life (months)
Aggregate
Intrinsic Value
(millions)
Under option —
As of January 1, 2023
35,506 $166.97 
Granted1,667 116.87 
Exercised(1,490)101.54 
Forfeited(1,000)166.62 
As of December 31, 2023
34,683 167.38 51$— 
Options exercisable
As of December 31, 2023
29,754 $170.24 43$— 
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award
The following table summarizes additional information relative to stock options exercised during the respective years:
(in millions)202320222021
Cash received from options exercised$147 $205 $457 
Intrinsic value of options exercised29 116 325 
Tax benefit realized related to options exercised24 69 
The following table summarizes additional information relative to restricted stock units for the respective years:
(in millions, except per-unit amounts)202320222021
Weighted-average grant-date fair value of restricted stock units (per unit) that were granted$114.71 $160.24 $176.82 
Intrinsic value of restricted stock units that vested$81 $88 $83 
Tax benefit realized related to restricted stock units that vested16 17 16 
The following table summarizes additional information relative to performance shares for the respective years:
(in millions, except per-share amounts)202320222021
Weighted average grant date fair value per performance share that were granted$110.21 $144.77 $176.79 
Intrinsic value of performance shares that were distributed$19 $21 $22 
Tax benefit realized related to performance shares that were distributed
Schedule of Stock Option Assumptions
202320222021
Exercise price$116.90 $162.41 $175.04 
Risk-free interest rate3.8 %1.9 %0.8 %
Dividend yield3.3 %2.9 %2.8 %
Expected volatility22.8 %21.8 %22.6 %
Expected life (months)848383
Black-Scholes fair value$22.22 $25.34 $25.33 
Schedule of Restricted Stock Units Activity The following table summarizes restricted stock unit activity:
(Units in thousands)Number of UnitsWeighted Average Grant Date Fair Value
Nonvested balance —
As of January 1, 2023
2,375 $164.07 
Granted2,372 114.71 
Vested(705)155.94 
Forfeited(244)136.06 
As of December 31, 2023
3,798 136.55 
Schedule of Performance Shares Activity
The following table summarizes performance share activity:
(Shares in thousands)Number of SharesWeighted Average Grant Date Fair Value
Undistributed balance —
As of January 1, 2023
391 $157.98 
Granted203 110.21 
Distributed(146)153.21 
Performance change(15)162.26 
Forfeited(73)137.66 
As of December 31, 2023
360 136.95